购物车
您的购物车当前为空
iNOS/COX-2-IN-3(compound 7d)为iNOS与COX-2的双重抑制剂,展现出针对LPS诱导的RAW 264.7细胞的抗炎活性(IC50=3.48 μM).该化合物在血浆中表现出优良的稳定性,具备口服活性及良好的胃部耐受性,其对iNOS和COX-2的抑制效力分别是Indomethacin的5.43倍和2.37倍.
iNOS/COX-2-IN-3(compound 7d)为iNOS与COX-2的双重抑制剂,展现出针对LPS诱导的RAW 264.7细胞的抗炎活性(IC50=3.48 μM).该化合物在血浆中表现出优良的稳定性,具备口服活性及良好的胃部耐受性,其对iNOS和COX-2的抑制效力分别是Indomethacin的5.43倍和2.37倍.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | iNOS/COX-2-IN-3 (compound 7d) is a dual inhibitor of iNOS and COX-2, demonstrating potential anti-inflammatory activity in LPS-induced RAW 264.7 cells (IC50=3.48 μM). This compound exhibits good plasma stability, oral activity, and gastric safety. Its inhibitory effects on iNOS and COX-2 expressions are 5.43 times and 2.37 times higher than those of Indomethacin, respectively. |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多